dromlakhani/md2skill/ata-oral-estrogen-gh-dose

Claude Code and agent skill by dromlakhani/md2skill

Trust tier 3
  • community
Source check pending

Checking that the SKILL.md file is still in the repository.

Suggests women on oral estrogen replacement receive higher GH doses compared to eugonadal females or males. Triggers when managing GH replacement in a woman on oral estrogen requiring GH therapy (e.g., "female on oral estrogen needing GH replacement").

Install

npx vskill@latest install dromlakhani/md2skill/ata-oral-estrogen-gh-dose

SKILL.md

The same SKILL.md was published earlier as dromlakhani/md2skill/ata-oral-estrogen-gh-dose.

Increase GH replacement dose for women on oral estrogen therapy

STEP 1 — Gather Information

Confirm female sex, oral estrogen use (type/dose), GH deficiency status, baseline IGF‑1, current GH dose, and presence of GH‑related symptoms or side effects.

STEP 2 — Rule In / Rule Out

Is the patient a woman receiving oral estrogen? If yes, proceed to dose adjustment; if no (eugonadal female, male, or transdermal estrogen), follow standard GH dosing protocols.

STEP 3 — Classify or Stratify

For women on oral estrogen, anticipate up to a 50% higher GH dose may be needed to achieve target IGF‑1 levels due to estrogen‑induced hepatic IGF‑1 suppression.

STEP 4 — Decide

Start GH at age‑based standard dose (0.2–0.4 mg/d if <60 y, 0.1–0.2 mg/d if ≥60 y) and titrate upward in 0.1–0.2 mg/d increments every 6 weeks, aiming for IGF‑1 in the mid‑ to upper‑normal range while monitoring for adverse effects.

Clinical Guardrails / Mimics / Pitfalls

Do not assume transdermal estrogen requires dose increase; avoid over‑replacement that causes fluid retention, arthralgia, or insulin resistance; always guide dosing by IGF‑1 and clinical response, not weight alone.

Concrete Clinical Example

A 45‑year‑old woman on oral estradiol 2 mg/day with GHD begins GH at 0.2 mg/d; after 6 weeks IGF‑1 is low‑normal, dose increased to 0.3 mg/d, IGF‑1 reaches target, and she reports improved energy without side effects.

Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, doi:10.1210/jc.2016-2118

Security

  • Security scanPassed, 90 of 100Pattern checks on the skill's files.
  • Model reviewPassed

Quality evaluation

  • Task evaluationNot runNo evaluation yet. Run one in Skill Studio.

Source

Popularity

Repository stars
12
Repository forks
1
7-day trend score
18

Stars and forks are for the whole GitHub repository, not this skill alone. Not refreshed yet.

Works with

Any agent vskill installs to: 56 targets in all. These 39 have a page on this site.

  • Claude Code
  • Cursor
  • GitHub Copilot
  • Windsurf
  • Codex
  • Gemini CLI
  • Cline
  • Amp
  • Roo Code
  • Goose
  • Continue
  • Kilo Code
  • Junie
  • Trae
  • OpenHands
  • Qwen Code
  • AI Agent
  • Tabnine Chat
  • Sourcegraph Cody
  • Amazon Q
  • Firebase Genkit
  • Sweep
  • Devin
  • Phind
  • Mentat
  • Claude Desktop
  • Aider
  • GPT Pilot
  • Plandex
  • bolt.new
  • v0
  • Replit Agent
  • Anse
  • TypingMind
  • BetterChatGPT
  • LibreChat
  • Warp AI
  • Pieces
  • Fig AI
Embed badge
vskill VERIFIED badge
[![vskill VERIFIED](https://verified-skill.com/api/v1/skills/dromlakhani/md2skill/ata-oral-estrogen-gh-dose/badge)](https://verified-skill.com/skills/dromlakhani/md2skill/ata-oral-estrogen-gh-dose)

Something wrong with this skill or its page? Tell us.